Cellromax Science Co., Ltd.

471820 KRX Consumer Staples Consumer Staples
KOSDAQ
₩4,035.00
+3.33%
Delayed · cached 15 min

Fair value analysis

471820
Cellromax Science Co., Ltd.
Consumer StaplesConsumer Staples
₩4,035.00
Close used for this calculation
₩4,654.82Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
43/100
Profitability2/25
Returns2/25
Balance Sheet25/25
Efficiency14/25
Growth10/25
Average
Quality radar
43Prof.2/25Ret.2/25Eff.14/25B.Sht25/25Growth10/25

Consensus fair value

₩4,654.82
Below FV
▲ +15.4% against the close used
Model range ₩1,800.62 – ₩5,280.00
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩1,800.62Fair value₩4,654.82Bull₩5,280.00
FairClose
52-week traded range
52W low ₩3,715.0052W high ₩6,980.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Cellromax Science Co., Ltd. closed at ₩4,035.00, 13.3% below the consensus fair value of ₩4,654.82 drawn from 6 valuation models.

Financial DNA score 43/100 — Average. P/E of 15.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩4,948.03
+22.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩4,996.66
+23.8%
√(22.5 × EPS × BVPS)
EPS=264, BVPS=4203.13
P/E Fair Value
₩5,280.00
+30.9%
EPS × 20x (sector P/E)
EPS=264, Sector P/E=20x
Dividend Discount (DDM)
₩1,800.62
-55.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=141.23, r=10%, g=2%
Reverse DCF
₩4,035.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 3.5% | Historical: 0%
Margin of Safety
₩3,806.17
-5.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=5074.9, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.